|
Volume 272, Number 9,
Issue of February 28, 1997
pp. 5647-5658
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Sequence-specific DNA Binding and Transcription Factor
Phosphorylation by Ku Autoantigen/DNA-dependent Protein
Kinase
PHOSPHORYLATION OF Ser-527 OF THE RAT GLUCOCORTICOID
RECEPTOR*
(Received for publication, June 27, 1996, and in revised form, December 11, 1996)
Ward
Giffin
,
Joanna
Kwast-Welfeld
,
David J.
Rodda
§¶,
Gratien G.
Préfontaine
§,
Maya
Traykova-Andonova
,
Yixian
Zhang
,
Nancy L.
Weigel
,
Yvonne A.
Lefebvre
§ and
Robert J. G.
Haché
§**
From the Departments of Medicine and
§ Biochemistry, University of Ottawa, Loeb Medical Research
Institute, Ottawa Civic Hospital, Ottawa, Ontario, Canada K1Y 4E9 and
the Department of Cell Biology, Baylor College of Medicine,
Houston, Texas 77030
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
ABSTRACT
NRE1 is a DNA sequence element through which Ku
antigen/DNA-dependent protein kinase (DNA-PK) catalytic
subunit represses the induction of mouse mammary tumor virus
transcription by glucocorticoids. Although Ku is an avid binder of DNA
ends and has the ability to translocate along DNA, we report that
direct sequence-specific Ku binding occurs with higher affinity
(Kd = 0.84 ± 0.24 nM) than DNA
end binding. Comparison of Ku binding to several sequences over which
Ku can accumulate revealed two classes of sequence. Sequences with
similarity to NRE1 competed efficiently for NRE1 binding. Conversely,
sequences lacking similarity to NRE1 competed poorly for Ku and were
not recognized in the absence of DNA ends. Phosphorylation of
glucocorticoid receptor (GR) fusion proteins by DNA-PK reflected Ku
DNA-binding preferences and demonstrated that co-localization of GR
with DNA-PK on DNA in cis was critical for efficient
phosphorylation. Phosphorylation of the GR fusion protein by DNA-PK
mapped to a single site, Ser-527. This site occurs adjacent the GR
nuclear localization sequence between the DNA and ligand binding
domains of GR, and thus its phosphorylation, if confirmed, has the
potential to affect receptor function in vivo.
INTRODUCTION
DNA-dependent protein kinase
(DNA-PK)1 is a nuclear kinase with a unique
catalytic requirement for direct DNA contact (1-4). Specific targeting
of DNA-PK to DNA binding sites in vivo is likely to be
critical for determining substrate phosphorylation for two reasons.
First, the affinity of DNA-PK for substrate (Km = 210 µM) is low. Second, DNA-PK is a broad specificity
kinase with a very simple recognition sequence (Ser-Gln or Thr-Gln) (1, 2). Therefore, the obligate linking of DNA-PK to DNA is expected to
favor phosphorylation of co-localized substrates in the cell nucleus.
Targeting of DNA-PKcs to DNA is by Ku autoantigen (p70/p80)
(4, 5), which is both a DNA-binding subunit of DNA-PK and an allosteric
regulator of kinase activity (5). Ku was first identified as a factor
stimulating autoantibody production in a variety of mixed connective
tissue autoimmune diseases (6, 7). Ku is an avid, but unusual,
DNA-binding protein. First demonstrated to bind DNA ends (7, 8), Ku is
now suspected to recognize virtually any DNA structure containing a
double- to single-stranded DNA transition (9). Remarkably, once bound to DNA, Ku is able to translocate from its point of entry (8). However,
while Ku translocates freely along DNA in vitro, it appears to be unable to translocate through a nucleosome (10). Thus, the
effective range of Ku translocation in vivo is likely to be quite limited.
DNA-PKcs has extensive similarity to the Ataxia
telangiectasia gene product and to the family of lipid kinases
that includes phosphatidylinositol 3-kinase (11-13). Recently, DNA-PK
has been shown to play important roles in double-stranded DNA break
repair and V(D)J recombination (14). Inactivation of
DNA-PKcs or Ku-p80 results in overlapping, but distinct
recombination and repair deficiencies (15-22). DNA-PKcs
has been shown to be required for the resolution of coding ends during
V(D)J recombination, and mutation in DNA-PKcs has been
proposed to account for the defects in the severe combined
immunodeficient (SCID) mouse. In addition to recruiting
DNA-PKcs to repair and recombination sites, Ku is proposed
to protect the ends of recombination and repair intermediates from
exonuclease digestion (23).
The relaxed substrate specificity of DNA-PK in vitro has led
to proposals for its participation in other nuclear processes, particularly transcription and DNA replication. For example, a role for
DNA-PK in repressing RNA polymerase I transcription has been suggested
(24-26). Additionally, a large number of sequence-specific transcription factors have been shown to be substrates for DNA-PK in vitro (1, 27, 28), suggesting a role in the regulation of
transcription by RNA polymerase II. Indeed, DNA-PK has recently been
shown to be associated with the RNA polymerase II holoenzyme (29).
As the targeting of Ku to transcriptional regulatory regions by
translocation from DNA ends is likely to very limited, the potential
ability of Ku to bind directly to transcriptional regulatory elements
has generated considerable interest. Over the past several years, there
have been numerous reports of the accumulation of Ku in
vitro over DNA sequence elements that function to regulate transcription (9, 30-37). It has not been clear, however, whether the
presence of Ku over these sequences represented direct
sequence-specific DNA recognition or the accumulation of Ku
translocated from the ends of the DNA fragments employed.
Recently, we demonstrated that a DNA sequence element, NRE1 (negative
regulatory element 1), in the long terminal repeat (LTR) of mouse
mammary tumor virus (MMTV) is a direct, sequence-specific, DNA binding
site for Ku/DNA-PKcs in the absence of DNA ends or other
structural features (38). In transfection experiments, NRE1
specifically repressed glucocorticoid hormone activated MMTV transcription in a Ku- and DNA-PKcs-dependent
manner. Further, in vitro, DNA-PK efficiently directed the
phosphorylation of glucocorticoid receptor (GR) and octamer
transcription factor 1 (Oct-1), two transcription factors that bind the
MMTV promoter in vivo in response to glucocorticoids
(39-41).
In the experiments presented here, we have examined the DNA
requirements for Ku binding and DNA-PK phosphorylation of rat GR in
detail. Our results demonstrate that sequence-specific Ku binding to
NRE1 is strongly preferred to DNA end binding and that DNA-PK catalytic
activity closely parallels Ku DNA-binding preferences. Furthermore, our
data indicate that only the subset of previously proposed
sequence-specific Ku binding sites with similarity to NRE1 are likely
to be direct sequence-specific Ku binding sites. Experiments with a GR
fusion protein substrate indicated that linkage of DNA-PK and substrate
in cis on DNA markedly increased the efficiency of substrate
phosphorylation. Intriguingly, phosphorylation of the GR fusion protein
occurred at Ser-527, in the region of the receptor connecting the DNA
and ligand binding domains and immediately adjacent to the dominant
nuclear localization sequence of the receptor.
MATERIALS AND METHODS
Oligonucleotides and Microcircles
Oligonucleotides were
synthesized on a Beckman Oligo 1000 DNA synthesizer. Sequences of the
upper-strands of oligonucleotides are shown in Fig. 1, except for the
oligonucleotide containing a binding site for nuclear factor 1 (NF1),
upper strand (5 -GTTCTTTTGGAATCTATCCAAGTCTTA-3 ). The NRE1 and PRE
oligonucleotides have been described previously (42). Microcircles
containing the GR- or C3H-MMTV NRE1 elements, four copies of a
consensus octamer motifs, the U1 small nuclear RNA PSE,
rc-mos IAP enhancer core or HSE were prepared as described previously from 223- or 292-bp pBluescript fragments containing one
(NRE1, U1, IAP, HSE) or four copies (octamer) of the individual oligonucleotides cloned into the SmaI site of pBluescript
(38). Purified recircularized DNA was completely resistant to S1
nuclease, exonuclease III, and Bal31.
Fig. 1.
Alignment of several sequences with the
potential for sequence-specific Ku binding suggests two categories of
motif. A, alignment of potential sequence-specific Ku
binding sites with extensive similarity to NRE1. Regulatory elements
with homology to the GR-MMTV NRE1 element (38, 42) include the C3H
element (59), the PRE upstream of the c-myc gene (57), and a
transcriptional repressor element in the U5 HTLV LTR (36). Matches with
NRE1 are uppercase, mismatches lowercase. An
overlapping direct repeat within the GR-MMTV NRE1 core is highlighted
by arrows. B, potential sequence-specific Ku
binding sites lacking obvious homology to NRE1. Proposed Ku binding
sites lacking homology to NRE1 include the octamer motif binding site
(34) of octamer transcription factors (octamer motif
underlined), the PSE from the U1 promoter (32), a heat shock
response element (31), and an enhancer core sequence from a recently
transposed (rc-mos) IAP LTR (63), which was subsequently
proposed to contain a Ku binding site (9).
[View Larger Version of this Image (18K GIF file)]
Plasmids and Recombinant Proteins
Expression and
purification of Ku from insect cells was essentially by the protocol of
Ono et al. (43). Baculovirus expression vectors VBB2-Kup86
and VBB2-Kup70tH6, encoding the p86 subunit and a
hexahistidine-tagged p70 subunit of human Ku autoantigen, respectively,
were co-infected into Sf9 cells. Three days post-infection, cells were
harvested and lysed by sonication in 40 mM HEPES, pH 7.9, 1 mM EDTA, 2 mM dithiothreitol, 0.1% Nonidet
P-40, 1 µg/ml leupeptin, 1 µg/ml pepstatin, and 1 mM
phenylmethylsulfonyl fluoride. Ku heterodimers were then purified using
a Ni2+ affinity resin (His-Bind Resin, Novagen).
pGEX-2T-X568 encoding glutathione S-transferase GR fusion
protein containing amino acids 407-568 of rat GR (GST-GR) was created by cloning the BamHI-EcoRI fragment of pSP64X568
(44) in frame into the BamHI-EcoRI sites of
pGEX-2T (Pharmacia). pGEX-2T-C500Y encoding GST-GR containing a Cys Tyr mutation at position 500 of the DBD (GST-GRC500Y) was
created by introduction of a BamHI-SmaI fragment
of pT7C500Y (45) in frame into the BamHI-SmaI
sites of pGEX-2T. GST fusion proteins were expressed in E. coli by growing transformed cells at 37 °C overnight, followed
by induction with 1 mM
isopropyl-1-thio- -D-galactopyranoside for 4-16 h at
23 °C. Induced bacteria were harvested and resuspended in lysis
buffer (25 mM HEPES, pH 7.9, 100 mM KCl, 20%
glycerol, 2 mM EDTA, 0.2 mM
phenylmethylsulfonyl fluoride) supplemented with 100 µg/ml lysozyme
and incubated for 10 min at 4 °C. Cells and DNA were sheared by
passage through a series of 18-, 20-, and 25-gauge needles, followed by
sonication 10 times for 40 s in the presence of 0.1% Nonidet P-40
at 4 °C. Lysates were centrifuged 10 min at 10,000 × g, and the supernatants were incubated with 3 ml of glutathione-Sepharose 4B beads (Pharmacia Biotech Inc.) for 90 min. The
beads were subsequently washed five times with 10 bed volumes of lysis
buffer and three times with 20 bed volumes of 60% lysis buffer
containing 0.1% Nonidet P-40. GST-GR beads were stored at 4 °C with
1 mM phenylmethylsulfonyl fluoride and 0.02% NaN3. To separate the GST domain from the DBD, 20 µl of a
1:1 slurry of beads were incubated with 0.5 units of thrombin (Novagen) at room temperature for 30 min.
pHC17 and pHC364 have been described previously (46). Linear and
covalently closed circular plasmids were prepared as described previously (38). Covalently closed circular plasmids were completely resistant to digestion with exonuclease III, Bal31, and S1
nuclease.
Electrophoretic Mobility Shift Assays (EMSAs)
Binding of
purified baculoviral Ku to 10.8 pmol of 32P-kinased
microcircle DNA was performed in 20 µl of 12 mM HEPES, pH
7.9, 12% glycerol, 60 mM KCl, 0.12 mM EDTA, 1 µg of BSA. 1 µg of highly sheared calf thymus DNA was included in
assays with Jurkat nuclear extracts. Binding reactions were incubated
for 20 min at room temperature. Monoclonal antibodies included in
mobility shift incubations included Ku antibody 162 (47), octamer
transcription factor-homeodomain antibody YL 15 (48), and GR antibody
BuGR (49). For competition experiments, increasing concentrations of
unlabeled oligonucleotides were added with the 32P-labeled
GR-MMTV NRE1 microcircle to the binding mix prior to addition of Ku.
Protein-DNA complexes were resolved by electrophoresis on 3%
polyacrylamide gels (acrylamide/bisacrylamide = 30:1) in 0.5 × TBE for 300 V-h. Gels were dried and exposed to autoradiography film
(DuPont) using Reflection intensifying screens (DuPont) and/or quantified by phosphorimage analysis using a Bio-Rad GS-525 Molecular Imager System.
The dissociation constant (Kd) of
baculovirus-expressed Ku for NRE1 containing microcircles was
determined in a manner similar to that described previously (50-52).
EMSA was performed with a constant amount of recombinant Ku incubated
with an increasing concentration of DNA (2.7-43.5 pmol) in a 40-µl
reaction volume. After electrophoresis the bound and free DNA were
quantified by phosphorimager. To determine the concentration of bound
DNA, a standard curve was created using the total (bound + free)
adjusted volume (counts × mm2) from the
phosphorimager versus concentration of total DNA. Total DNA
concentration was determined by subsequent scintillation counting of
excised bands (Beckman LS-3801). Labeling efficiency was 100%, as
formation of covalently closed microcircles required incorporation of
[ -32P]dATP during fill in of the XhoI site
prior to microcircle ligation. Kd was determined by
Scatchard analysis (Kd = 1/slope) in three
independent trials and expressed as mean ± S.E.
Phosphorylation of GST-GR by DNA-PK
Phosphorylation of
GST-GR by DNA-PK was performed essentially as described previously (38)
using 10 ng of supercoiled, linear, or covalently closed circular pHC17
or pHC364. Plasmids were linearized with HindIII as
indicated and, in some instances, recircularized with T4 DNA ligase.
Supercoiled, covalently closed circular, and linear plasmids were
purified through agarose gels prior to use in kinase assays. Kinase
reactions were carried out for 15 min at 30 °C in kinase buffer (50 mM HEPES, pH 7.5, 100 mM KCl, 10 mM
MgCl2, 0.2 mM EGTA) using 10 ng of plasmid DNA,
0.5 units of DNA-PK (Promega), 5 µCi of [ -32P]ATP
(6000 Ci/mmol, DuPont), and 5-15 µl of a 1:1 slurry of GST-GR bound
to glutathione-Sepharose beads, prewashed twice in kinase buffer.
Following kinasing, the beads were washed three times in kinase buffer
to remove free [ -32P]ATP. The GST-GR was eluted by
boiling in SDS-PAGE sample buffer prior to or following thrombin
cleavage as indicated. 32P incorporation was determined by
autoradiography or phosphorimage analysis of 12% SDS-PAGE gels.
Identification of DNA-PK Phosphorylation Sites on
GST-GR
Phosphorylated GST-GR was recovered from SDS-PAGE gels,
digested with L-1-tosylamido-2-phenylethyl chloromethyl
ketone-treated trypsin, and analyzed by reverse-phase HPLC and
electrophoresis on 40% alkaline polyacrylamide gels as described
previously (53). Prior to further manipulation, tryptic peptides were
eluted from alkaline polyacrylamide gels, dried, redissolved in 0.1%
trifluoroacetic acid, and purified over SepPak C18 columns
(Millipore).
Digestion of purified phosphopeptide with sequencing grade
endoproteinase AspN (Boehringer Manheim) was performed using 0.2 µg
of AspN (54) in 200 µl of 50 mM sodium phosphate buffer, pH 8.0, for 8-16 h at 37 °C. Additional aliquots of AspN were added
at 4-h intervals. Digestion products were resolved on 40% alkaline
polyacrylamide gels (55).
Manual [32P]phosphate release studies were performed on
purified peptide according to a protocol originally described by
Sullivan and Wong (56), as modified by Zhang et al. (53).
Phenylisothiocyanate was obtained from J. T. Baker Inc. Triethylamine,
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, and trifluoroacetic acid
were obtained from Sigma. Sequelon-AA membrane was
obtained from Millipore Corp. (Milford, MA).
RESULTS
Specificity of DNA Recognition by Ku Autoantigen
Recently, we
demonstrated that Ku antigen bound on fully relaxed, covalently closed
circular DNA, to a region of the LTR from the GR strain of MMTV ( 397
and 375) centered over NRE1 (38). Furthermore, in EMSA a 23-bp
oligonucleotide spanning LTR sequences 398 and 376 was sufficient
for Ku binding to a microcircle (38). Previously, a number of other
potential sequence-specific Ku binding sites had been proposed (9, 24,
30-37). However, these experiments could not distinguish between
direct sequence-specific binding of Ku and accumulation of Ku
translocated from a DNA end.
Alignment of these proposed Ku binding sites with NRE1 revealed two
types of DNA sequence, several examples of which are displayed in Fig.
1. First, regulatory elements flanking the murine
c-myc gene (57, 58) and in the LTR of human T cell leukemia
virus (HTLV) (36) have the same overall polypurine character as NRE1 and considerable sequence identity (Fig. 1A). In the C3H
strain of MMTV, there is a similar conservation over NRE1 and this
region of the C3H LTR has similarly been implicated in regulating viral transcription (59-61). A second category of potential
sequence-specific Ku binding site is composed of sequences with no
apparent homology to NRE1, or even to each other (Fig. 1B).
This group of sequences includes the octamer motif bound by octamer
transcription factors (34), a heat shock response element (31), an
element from the U1 small nuclear NA promoter (32), and a high affinity
EBP80 binding site from the rc-mos intracisternal A particle
(IAP) LTR (9, 62, 63). The lack of similarity to NRE1, or indeed to
each other, is clearly suggestive of an alternative mechanism for the
recognition of these sequences by Ku. In order to begin to distinguish
the requirements for Ku binding to different DNA sequences and
structures, we compared the binding of Ku to NRE1 with Ku binding to
NRE1-like sequences, unrelated sequences, and DNA ends.
The human Ku protein used in this study was prepared from baculovirus
as described previously (43), with the cDNA for the p70 subunit
encoding a histidine tag used to purify the Ku heterodimer by nickel
affinity chromatography (Fig. 2A). This form
of Ku recognizes NRE1 indistinguishably from human Ku purified from
Jurkat T cells (38). In the first experiment (Fig. 2B), we
compared Ku binding to the NRE1 elements in the LTRs of the GR- and C3H
MMTV strains on covalently closed microcircles. The microcircles used
in these assays were gel-purified and resistant to digestion with
exonuclease III, Bal31, and S1 nuclease, ensuring the absence of nicks
and structural features in the microcircles
(38).2 The C3H-NRE1 element has several
differences in sequence from the GR element, but retains the overall
polypurine character of GR-NRE1 (Fig. 1A). Incubation of
microcircles containing either GR-NRE1 (Fig. 2, B and
C, lanes 1-4) or C3H-NRE1 (Fig. 2B,
lanes 5-8) with recombinant Ku expressed from baculovirus
resulted in the formation of a protein-DNA complex in EMSA that was
supershifted by an antibody to Ku, but unaffected by a glucocorticoid
receptor antibody. No binding was detected to microcircles lacking an
NRE1 insert.2 However, over several repetitions of the
binding assay, Ku binding to C3H-NRE1 microcircles was consistently
about 4-fold lower than binding to the GR-NRE1 microcircles. Thus,
while the sequence differences between the GR- and C3H-NRE1 elements do
not prevent recognition by Ku, they do appear to influence the affinity
of binding.
Fig. 2.
Ku binds specifically to the NRE1 element in
of the C3H strain of MMTV, but is unable to bind an octamer motif.
A, silver-stained gel of recombinant Ku purified from
baculovirus-infected insect cells by chromatography over a
Ni2+ affinity column. Lanes 1 and 3 show the pattern of staining in the crude extract obtained from
mock-infected and Ku-infected Sf9 cells, respectively. Lanes
2 and 4 show the Ni2+ affinity column
eluates. B, EMSA comparison of recombinant Ku binding to GR
(lanes 1-4) and C3H NRE1 sequences (lanes 5-8)
on covalently closed circular microcircles resistant to exonuclease III, Bal31, and S1 nuclease. XhoI/PvuII
microcircles of 223 bp (lanes 1-4) or 227 bp (lanes
5-8) prepared from pBluescript containing NRE1 oligonucleotides
from the GR (lanes 1-4) and C3H (lanes 5-8) strains of MMTV were electrophoresed through a 3% polyacrylamide gel
following incubation in the presence of 1 µg of highly sheared calf
thymus DNA and in the presence or absence of recombinant Ku and/or
specific and nonspecific antibodies as indicated. Ku Ab 162 is a
monoclonal antibody (Ab) that supershifts Ku-DNA complexes, while nonspecific (N.S.) antibody BuGR is a glucocorticoid
receptor monoclonal antibody that is unable to recognize Ku. The 1 µl
of recombinant Ku added in the GR-NRE1 binding assays resulted in approximately 40% of the Ku-microcircle complexes obtained with 10 µl of Ku added to the C3H-NRE1 microcircle, as measured by phosphorimager. C, evaluation of Ku binding to a 223-bp microcircle containing the GR-MMTV NRE1
element (lanes 1-4) and binding to a 300-bp microcircle
containing 4 copies of an oligonucleotide with a consensus octamer
motif (lanes 5-9). Lanes 1 and 5 show the results of control incubations in the absence of Ku and Jurkat nuclear extract. In lanes 2-4 the NRE1-containing
microcircle was incubated with 1 µl of recombinant Ku (lane
2) together with Ku Ab 162 (lane 3) or nonspecific
antibody BuGR (lane 4). Lanes 6-9 show the
results of incubation of the octamer motif-containing microcircle with
10 µl of Ku (lane 6) or 1 µg of Jurkat nuclear extract
(N.E., lanes 7-9) in the presence of Oct
homeodomain antibody YL15 that supershifts octamer proteins bound to
DNA (lane 8) or Ku Ab 162 (lane 9).
[View Larger Version of this Image (25K GIF file)]
To compare direct Ku binding to NRE1 with binding to a proposed
sequence-specific Ku binding site unrelated in sequence to NRE1, we
evaluated the binding of Ku to microcircles containing octamer motifs
(Fig. 2C). By contrast to NRE1 binding, recombinant Ku was
unable to recognize microcircles containing four copies of an octamer
motif oligonucleotide (Fig. 2C, lane 6). This
finding was consistent with our previous result that the two octamer
motifs in the MMTV LTR were unable to support DNA-PK activity in the absence of DNA ends (38). To confirm that Ku was unable to bind covalently closed circular DNA containing octamer motifs, we repeated the binding assay with nuclear extract prepared from Jurkat T cells,
which contain an abundance of both octamer transcription factors and Ku
(38, 64). Incubation of the octamer motif-containing microcircle with
Jurkat nuclear extract led to the formation of a complex that was
supershifted (Fig. 2C, lanes 7 and 8)
by an antibody that is known to supershift octamer transcription
factors (48). The Ku antibody was, however, completely unable to modify the shifted complex obtained with Jurkat extract (lane 9).
Previously, we demonstrated that this antibody effectively supershifted
Jurkat nuclear extract Ku binding to NRE1 (38). Therefore, we conclude that the C3H-MMTV NRE1-like sequence is, like its GR counterpart, a
direct, internal, sequence-specific binding site for Ku antigen; however, a consensus octamer motif is not directly recognized by
Ku.
In a second experiment, we compared the ability of oligonucleotides
from the two categories of proposed Ku binding site, and completely
nonspecific DNA, to compete binding of recombinant Ku to microcircles
containing NRE1 from the GR strain of MMTV (Fig. 3). As
direct sequence-specific Ku binding to NRE1 was resistant to a large
excess of highly sheared calf thymus DNA (Fig. 2), we anticipated that
oligonucleotide competition experiments might be used to distinguish
direct sequence-specific DNA binding from the entry of Ku onto DNA from
the ends. Oligonucleotides containing the MMTV GR- (Fig. 3A)
and C3H-NRE1 elements (Fig. 3B), the c-myc plasmacytoma repressor factor binding site (PRE, Fig. 3C)
and the NRE1 homology in the HTLV LTR (Fig. 3D) efficiently
competed for Ku binding to NRE1-containing microcircles (summarized in Fig. 3L). A 100-fold excess of unlabeled oligonucleotides
competed up to 90% of Ku binding to the microcircle (Fig. 3,
A-D, lanes 5). The GR NRE1 element was
reproducibly the most efficient competitor, again suggesting that the
sequence differences between MMTV GR-NRE1 and the other NRE1-like
sequences result in a reduced affinity for Ku.
Fig. 3.
Competition of Ku binding to GR-MMTV
NRE1-containing microcircles in EMSA. A-I, 1 µl of
recombinant Ku was incubated with 32P-labeled 223-bp
covalently closed circular GR-MMTV NRE1 containing microcircles
prepared from pBluescript in the presence of increasing amounts of the
oligonucleotides indicated. The sequences and origin of the individual
oligonucleotides used are shown in Fig. 1, except for I,
where the competition was performed with an oligonucleotide containing
an NF1 recognition sequence that is described under "Materials and
Methods." Amounts of competing oligonucleotides were as follows:
lanes 1, no competitor; lanes 2, 5 ng;
lanes 3, 25 ng; lanes 4, 50 ng; lanes
5, 200 ng. J, competition experiment performed as in
A-I except that 25 ng (lane 2), 50 ng
(lane 3), 200 ng (lane 4), and 500 ng (lane
5) of a 200-bp XhoI/PvuII pBluescript fragment was used as competitor. K, NRE1-containing
microcircle electrophoresed in the absence of added Ku antigen. Each
binding experiment in A-J was performed a minimum of three
times with similar results. L and M,
quantification of competition for NRE1 binding results shown in
A-J as determined by phosphorimager. The amount of
radioactivity contained in the Ku antigen-shifted complexes is plotted
as a percentage of counts detected in the absence of competitor
(lanes 1). The variation in the total number of counts
loaded in each lane of each series was less than 5%. The dotted
lines mark the amount of NRE1-microcircle binding in the absence
of competitor. L, competition results for oligonucleotides with similarity to NRE1. Competitors were: GR-NRE1 ( ), C3H-NRE1 ( ), c-myc PRE (×), and HTLV LTR ( ). M,
competition results for oligonucleotides with no obvious similarity to
NRE1. Competitors were: octamer motif ( ), U1 PSE ( ), HSE (×),
IAP ( ), NF1 binding site ( ), and linear pBluescript fragment
( ). For the linear XhoI/PvuII pBluescript
fragment, 87% of NRE1-microcircle binding remained following
competition with 500 ng of DNA.
[View Larger Version of this Image (34K GIF file)]
By contrast oligonucleotides containing sequences from the second
category of proposed Ku binding site, including the U1 promoter element
(Fig. 3E), the heat shock element (Fig. 3F), the
EBP80 binding site (Fig. 3G), and the consensus octamer
motif (Fig. 3H), competed poorly for Ku binding to NRE1
(summarized in Fig. 3 M). Indeed, none of these sequences
even competed Ku binding as well as an oligonucleotide containing a
transcription factor binding site that to date has not been associated
with Ku (Fig. 3, I and M), nor did they compete
more efficiently than a 200-bp linear DNA fragment derived from
pBluescript and known to lack sequence-specific Ku binding sites (38)
(Fig. 3, J and M). These experiments indicate
that category two Ku binding sites (Fig. 1) could not be distinguished
from DNA end binding.
In the experiments displayed in Fig. 2, we demonstrated that one
category two site, the octamer motif, appeared unable to function as a
direct internal binding site for Ku on covalently closed circular DNA.
To test directly whether the other category two oligonucleotides (Fig.
1B) might be also unable to be directly recognized by Ku in
the absence of DNA ends, we assessed the ability of Ku to bind directly
to covalently closed circular DNAs containing the U1, IAP, and HSE
oligonucleotides (Fig. 4). While NRE1-containing microcircles were readily shifted by Ku (lanes 2 and
3), no detectable binding was observed to the U1
(lanes 5 and 6), IAP (lanes 8 and 9), or HSE-containing microcircles (lanes 11 and
12).
Fig. 4.
Direct binding of Ku to
oligonucleotide-containing microcircles. 1 µl of recombinant Ku
was incubated with 32P-labeled 223-bp covalently closed
circular microcircles prepared from pBluescript containing single
copies of the GR-NRE1 (lanes 1-3), U1 PSE (lanes
4-6), rc-mos IAP enhancer core (lanes
7-9), or HSE (lanes 10-12) in the absence
(lanes 1, 4, 7, and 10) or presence (lanes 2, 5, 8,
11) of Ku antibody Ab 162 (lanes 3, 6, 9, and 12). Lane 1 shows the
covalently closed microcircles following a mock incubation in the
absence of Ku.
[View Larger Version of this Image (51K GIF file)]
Two conclusions can be made from these experiments. First, Ku binding
to NRE1-like sequences is markedly preferred to DNA end binding.
Second, the subset of proposed Ku binding sites lacking obvious
homology to NRE1 did not appear to function as direct, internal, high
affinity Ku DNA binding sites in our experiments. Furthermore, it
appears that oligonucleotide competition experiments can distinguish
between direct, sequence-specific Ku binding and the entry of Ku onto
DNA from the DNA ends.
Affinity of Direct Binding to NRE1
To determine the affinity
of direct Ku binding to NRE1, we used EMSA to perform Scatchard
analyses of the binding of a constant amount of Ku to an increasing
amount of GR-NRE1-containing microcircle (Fig. 5). For
this assay we took advantage of the recircularization protocol for the
223-bp NRE1-containing DNA fragment that requires incorporation of a
single 32P label for formation of the covalently closed
circular microcircle (38). Thus, the labeling efficiency of the
purified microcircles used in this assay was 100%, allowing exact
determination of the quantity of DNA in each incubation. A
representative EMSA and Scatchard analysis is shown in Fig.
5A. Averaging of three independent experiments yielded a
Kd of 0.84 ± 0.24 nM for direct sequence-specific DNA binding of recombinant Ku to NRE1. This value is
comparable with the values obtained for the sequence-specific DNA
binding of many transcription factors.
Fig. 5.
Determination of the affinity of Ku binding
to NRE1. A, electrophoretic mobility shift assay with
increasing amounts of 32P-labeled GR-MMTV NRE1-containing
microcircle DNA and a constant 1-µl amount of recombinant Ku. The
amounts of DNA probe added to each incubation were 2.7 pmol (lane
1), 5.4 pmol (lane 2), 10.8 pmol (lane 3),
21.7 pmol (lane 5), and 43.5 pmol (lane 6) as
determined by scintillation counting. B, bound and free DNAs in panel A were quantified by phosphorimager and the
Kd of NRE1 binding to Ku was determined by Scatchard
analysis. One representative Scatchard plot is displayed together with
the Kd (± S.E.) calculated from three independent
repetitions of the assay.
[View Larger Version of this Image (29K GIF file)]
Properties of Sequence-directed Phosphorylation of GR by
DNA-PK
Protein phosphorylation by DNA-PK is dependent on the
tethering of the catalytic subunit of the kinase to DNA by Ku (5). While DNA-PKcs also contacts the DNA, it has been proposed
that Ku is entirely responsible for the DNA targeting of the complex. If this is correct, DNA-PK-mediated protein phosphorylation should directly reflect Ku DNA binding preferences. To determine how the
protein kinase activity of DNA-PK compared with the DNA binding preferences of Ku, we analyzed the DNA sequence preferences for phosphorylation of GR on the MMTV LTR by purified DNA-PK (65).
We first examined the conditions required for DNA-PK-mediated
phosphorylation of a bacterial-expressed GST-GR fusion protein containing the DBD of GR (Fig. 6A). The first
GST-GR protein tested contained the wild type GR DBD (WT,
lane 1), while the second contained a Cys to Tyr mutation
(C500Y, lane 2) in the second zinc finger of the DNA binding
domain that results in a GST-GR fusion protein that is unable to bind
DNA (45).
Fig. 6.
NRE1-dependent phosphorylation of
recombinant GST-GR by DNA-PK in vitro. A, silver
stain of a 12% SDS-PAGE gel of slurries of 5 µl of wild type GST-GR
recombinant protein (GR) and 15 µl of mutated GST-GR
fusion protein containing a Cys-500 Tyr substitution in the GR
moiety (GST-GRC500Y) attached to glutathione-Sepharose beads. Some preparations of GST-GR contained a second minor fusion protein band just above the 46-kDa band (see for example panel C). B, phosphorylation of rat GR recombinant protein
(GST-GR) by DNA-PK was performed using 10 ng of the
indicated DNAs and equal quantities (5 or 15 µl) of GST-GR fusion
proteins and 0.5 unit of DNA-PK. The components added to each
incubation are summarized above the lanes. For DNAs: 17,
pHC17; 364, pHC364; L, linear; SC,
supercoiled; CC, covalently closed circular; , no added
DNA. For DNA-PK: +, 0.5 unit of DNA-PK added; , no DNA-PK added. For GR: , 30 µl of mock E. coli extract slurry; +, 5 µl of
affinity-purified recombinant GST-GR of rat GR expressed in E. coli; GST-GRC500Y, 15 µl of affinity-purified
mutated GST- recombinant protein unable to bind DNA. pHC17 contains
both NRE1 and the GRE from the GR-MMTV LTR ( 421/+105), while pHC364
is truncated 3 to NRE1 ( 364/+105). C, phosphorylation of
GST-GR by DNA-PK on the covalently closed circular pHC17 DNA in the
absence (lane 1) or presence of a 200-fold excess (1 µg)
of covalently closed circular competing DNAs (lane 2 and
3). pBl-CC, pBluescript with no specific Ku
binding site; 364-CC, pHC364 containing GRE but no NRE1
sequence. The migration of molecular size markers (kDa) is indicated to
the left of panels A and B.
[View Larger Version of this Image (17K GIF file)]
Phosphorylation of GST-GR by DNA-PK (Fig. 6B) was evaluated
using two MMTV LTR containing plasmids as DNA templates for purified DNA-PK. pHC17 ( 421/+105), contained NRE1 and the
glucocorticoid-responsive element (GRE, 180/ 80) from the GR-MMTV
LTR (38, 46). The second plasmid, pHC364 ( 364/+105), retained the
viral GRE and octamer transcription factor binding sites but lacked
NRE1 (38, 46). In this, and subsequent experiments, phosphorylation did not occur in the absence of any of the three components (DNA-PK, GST-GR, DNA, lanes 1-3). When linearized plasmids allowing
Ku DNA end binding were used at the concentration previously described as optimal for DNA-PK-mediated phosphorylation of factors from DNA ends
(5), both plasmids directed phosphorylation of GST-GR equally
(lanes 4 and 5). As described in detail below
(Fig. 8), phosphorylation occurred at a single site in the GR DBD.
However, when pHC17 and pHC364 were recircularized to a covalently
closed circular form resistant to nucleases ExoIII, S1, and Bal31, only the NRE1-containing plasmid (pHC17) was able to direct phosphorylation of GST-GR (lanes 6 and 7). Interestingly, the
same results was obtained with supercoiled plasmids with the potential
for localized structural transition from B form DNA (lanes 8 and 9). Therefore, parallel to the DNA binding activities of
Ku determined above, while NRE1 efficiently directed phosphorylation of
GST-GR by DNA-PK, the two octamer transcription factor binding sites in
the MMTV LTR were unable to direct the phosphorylation of GR by
DNA-PK.
Fig. 8.
GST-GR is phosphorylated in the GR DBD.
A, silver-stained 12% SDS-PAGE gel of GST-GR before
(lane 1) and after cleavage with thrombin (lane
2). An independent preparation of GST alone is shown in lane
3. The positions of GST-GR, GST, and the GR DBD alone are
indicated by the arrows to the right of the gel.
B, phosphorimager scan of GST-GR phosphorylated by DNA-PK
(lane 1) and following thrombin cleavage (lane
2). For both panels the migration of molecular size markers (kDa)
are indicated to the left of the gels.
[View Larger Version of this Image (22K GIF file)]
Phosphorylation of GST-GR by DNA-PK in these experiments also appeared
to require that GST-GR be bound to pHC17 in cis with DNA-PK.
First, GST-GRC500Y was not phosphorylated by DNA-PK in this
assay, regardless of the presence of NRE1 (Fig. 6B,
lanes 10 and 11). Second, phosphorylation of
GST-GR in the presence of pHC17 (Fig. 6C, lane 1)
was effectively competed by addition of covalently closed circular
pHC364 (lane 3), but was unaffected by addition of
covalently closed circular pBluescript, a plasmid lacking GREs
(lane 2).
To examine further how Ku DNA binding preferences influenced DNA-PK
activity, we examined the effect of competitor DNAs on the GRE
dependent phosphorylation of GST-GR (Fig. 7). In these experiments the competitor DNAs employed lacked GREs and thus were
unable to compete for DNA binding of GST-GR. In the first experiment
(Fig. 7, A and D), a covalently closed circular
pBluescript plasmid containing a single copy of a 23-bp NRE1
oligonucleotide efficiently competed phosphorylation of GST-GR on
linearized pHC364 plasmid lacking NRE1. By contrast under the same
conditions, neither the linearized nor covalently closed circular
pBluescript parent plasmid lacking NRE1 appreciably competed the
phosphorylation of GST-GR on covalently closed circular pHC17 plasmid
containing both NRE1 and the MMTV-GRE (Fig. 7, B-D). Thus,
as for the binding of recombinant Ku to DNA, phosphorylation of
DNA-bound GST-GR by purified DNA-PK displayed a marked preference for
NRE1 over DNA ends.
Fig. 7.
Competition of DNA-PK-mediated GST-GR
phosphorylation with Ku DNA binding sites. A,
phosphorylation of GR was performed using 10 ng of linear pHC364
(Lin pHC364) in the absence (lane 1) or presence
of the indicated amounts of the covalently closed circular pBluescript
plasmid (CC pNRE1) containing a single copy of the GR-MMTV
NRE1 oligonucleotide shown in Fig. 1. B and C, phosphorylation of GR was performed using covalently closed circular pHC17 (CC pHC17) in the absence (lane 1) or
presence of the indicated amounts of linear (B) or
covalently closed circular (C) pBluescript (Lin
pBlue and CC pBlue) parent plasmid. D,
quantification of the results shown in A ( ), B
( ), and C (×), as determined by phosphorimager analysis
of SDS-PAGE gels. The data (± S.E.) is plotted as a percentage of the
total GST-GR phosphorylation in the absence of competitor DNA. Each
point is derived from three independent repetitions of the assays shown
in A-C.
[View Larger Version of this Image (27K GIF file)]
Identification of Ser-527 of the GR DBD as a Phosphorylation Target
of DNA-PK
As a first step toward characterizing the potential
effects of the phosphorylation of GR by DNA-PK on the regulation of
MMTV transcription by glucocorticoids (38), we sought to identify the
DNA-PK phosphorylation sites on the GST-GR DBD fusion protein used in
this study. GST-GR contains a single thrombin cleavage site between the
GST and GR DBD moieties of the fusion protein. Following thrombin
cleavage of GST-GR, the GST peptide migrated at 29 kDa, while the GR
DBD migrated at 26 kDa on SDS-PAGE (Fig. 8A).
Autoradiography of an SDS-PAGE gel containing
32P-phosphorylated GST-GR cleaved with thrombin revealed a
single labeled fragment migrating at the position of the GR DBD (Fig. 8B). This radiolabeled peptide could be immunoprecipitated
by a GR antibody, but not by a nonspecific control
antibody.2 Thus, DNA-PK appeared to
specifically phosphorylate the DBD of the rat GR fusion protein and not
the GST moiety.
Cleavage of 32P-phosphorylated GST-GR with trypsin resulted
in the liberation of a single radiolabeled phosphorylated peptide as
determined by both reversed phase HPLC3 and electrophoresis
on a 40% alkaline PAGE gel (Fig. 9A). The identity of the phosphorylated GR residue was determined in two steps.
First, manual Edman degradation of the tryptic phosphopeptide recovered
from the polyacrylamide gel released the 32P label on cycle
10 (Fig. 9B). As shown in Table I, tryptic
digestion of the GR DBD produces three peptides with Ser or Thr at
position 10. Each peptide also contains Asp, but at a different
positions, suggesting that AspN, a protease that cleaves N-terminal to
Asp (54) could be used to determine which peptide was the DNA-PK target.
Fig. 9.
DNA-PK phosphorylates position 10 of the
peptide obtained after cleavage of GST-GR with trypsin. A,
phosphorimage analysis of a 40% alkaline PAGE gel containing
recombinant GST-GR phosphorylated by DNA-PK and digested with trypsin.
B, plot of 32P released from the phosphopeptide
shown in A upon subsequent cycles of Edman degradation. The
radioactivity released after each cycle was quantified by scintillation
counting. Values were corrected for the background radioactivity
(25 ± 4 dpm) of a sample blank.
[View Larger Version of this Image (10K GIF file)]
Secondary digestion of the DNA-PK-phosphorylated
[ -32P]GST-GR tryptic peptide fragment with AspN
yielded a 32P-labeled peptide with increased mobility on
alkaline PAGE (Fig. 10A), confirming the
presence of Asp in the tryptic peptide fragment. Edman degradation of
the trypsin/AspN cleaved fragment again led to release of the
32P-labeled amino acid at position 10 (Fig.
10B). This identified Ser-527 of the GR DBD as the DNA-PK
phosphorylation site as only GR DBD tryptic peptide 518-536 would
release Ser or Thr at position 10 following AspN digestion of the
tryptic peptide. Furthermore, there are no comparable tryptic peptide
fragments in the GST moiety of the fusion protein. Finally, the amino
acid following Ser-527 in the GR DBD, Gln-528, conforms exactly to the
amino acid requirements for phosphorylation by DNA-PK (Ser-Gln or
Thr-Gln) (2). This is the only consensus DNA-PK phosphorylation site in
the GR DBD fragment used in this study. Interestingly Ser-527 lies in
the hinge region of GR that connects the DNA binding domain with the ligand binding domain and is immediately adjacent to the major nuclear
localization sequence of GR (497-524) (66).
Fig. 10.
DNA-PK phosphorylates Ser-527 of the rat GR
DBD. A, phosphorimage analysis of a 40% alkaline PAGE gel
containing recombinant GST-GR phosphorylated by DNA-PK and digested
with trypsin (lane 1) or digested with trypsin and AspN
(lane 2). B, plot of 32P released
from the AspN digested phosphopeptide shown in A upon subsequent cycles of Edman degradation. The radioactivity released after each cycle was quantified by a scintillation counting. Values were corrected for the background radioactivity (25 ± 4 dpm) of a
sample blank. Ser-527 is the only possible Ser/Thr in GST-GR that can
release 32P at cycle 10 following both trypsin and
trypsin/AspN digestion.
[View Larger Version of this Image (16K GIF file)]
DISCUSSION
Targeting of Ku autoantigen and DNA-PKcs to the LTR of
MMTV appears to strongly repress the induction of viral transcription by glucocorticoids (38). In this study we have investigated the
properties of sequence-specific binding of Ku to the LTR of MMTV, its
effect on DNA-PK catalytic activity, and the nature of
sequence-directed phosphorylation of a GR fusion protein co-localized to the MMTV promoter in vitro. Our results indicate that
direct sequence-specific binding of Ku to NRE1-like sequences occurs with high affinity, is strongly preferred to DNA end binding, and
apparently requires similarity to, but not identity with, NRE1. Several
proposed sequence-specific Ku binding sites lacking similarity to NRE1
failed to bind Ku in the absence of DNA ends. Catalytic activity of the
Ku-associated DNA-PKcs closely paralleled Ku DNA-binding
site preferences. Furthermore, efficient phosphorylation of a GR fusion
protein substrate required that both GR and DNA-PK be localized to the
MMTV LTR in cis. Finally, we have identified Ser-527 in the
hinge region of GR as an in vitro phosphorylation target
of DNA-PK.
A number of sequence-specific binding sites have been proposed for Ku
autoantigen (24, 30-37, 67), but to date only one site, NRE1 in the
long terminal repeat of the GR-strain of MMTV, has been shown to be
directly recognized by Ku in the absence of DNA ends (38). Here we have
demonstrated that the related sequence in the LTR of the C3H strain of
MMTV is also a direct, sequence-specific Ku binding site, but that the
sequence differences between the elements in the two strains reduce
binding to the C3H motif approximately 4-fold. Interestingly, although
the C3H MMTV NRE1 element was of lower affinity than the NRE1 element from the GR strain of MMTV, it was still clearly distinguishable from
Ku DNA end binding in oligonucleotide competition experiments. Furthermore, the difference in affinity does not appear to affect the
functionality of the C3H NRE1 element, as there is a report that
sequences including the C3H NRE1 element also act to repress C3H-MMTV
transcription (59).
Scatchard analysis with covalently closed microcircles containing a
32P label indicated a binding constant for direct Ku
binding to NRE1 of 0.84 ± 0.24 nM, comparable with
the values for the DNA binding affinity of many transcription factors.
Although this value is only 3-fold higher than that reported for DNA
end binding of a purified Ku preparation in a similar assay
(Kd = 2.4 9 M) with a short
linear nonspecific oligonucleotide (68), our present and previous (38)
competition experiments suggest that the difference in affinity between
sequence-specific NRE1 binding and DNA end binding by Ku under
equivalent incubation conditions is likely to be at least an order of
magnitude. Additional experiments performed by an alternative assay
demonstrated that the affinity of Ku for DNA ends was equivalent to its
affinity for structural transitions and DNA nicks (9). Therefore, our
results indicate that the GR-MMTV NRE1 element is, at least in
vitro, the highest affinity DNA binding site for Ku identified to
date.
In addition to the NRE1 motif, we evaluated Ku binding to a number of
previously proposed Ku binding sites. Our results indicated two classes
of sequence element. DNA elements in the LTR of HTLV and flanking the
murine c-myc gene, which have been demonstrated to
participate in repressing transcription (36, 58), have obvious sequence
similarity to NRE1. These sequences competed efficiently for
sequence-specific NRE1 binding in oligonucleotide competition
experiments and therefore will likely prove to be direct, high affinity
sequence-specific Ku binding sites. However, an important caveat to
performing oligonucleotide competition experiments for analyzing Ku
binding is that one must be careful to distinguish direct,
sequence-specific DNA binding from DNA end binding. Therefore,
conclusive evidence for direct sequence-specific binding of the
c-myc plasmacytoma repressor factor and HTLV sequences will
require that binding assays be performed with covalently closed
circular templates. Nonetheless, the identification of four apparent
direct, sequence-specific, Ku binding sites makes it tempting to
speculate on the nature of a consensus sequence for direct
sequence-specific Ku binding. Certainly, the polypurine/polypyrimidine nature of the recognition sequence is conserved in all four sites. However, experiments currently in progress indicate that the minimum length of the polypurine/polypyrimidine sequence required for direct
binding may be considerably less than the 14 bp of the GR-NRE1
element.4 Nucleotides outside the
polypurine/polypyrimidine core may also play a role in Ku binding.
Thus, determining exact requirements for sequence-specific Ku binding
will require more extensive DNA binding analyses of the type provided
by binding site selection techniques.
By contrast, the majority of the potential sequence-specific Ku binding
sites proposed to date lack obvious homology to NRE1. Four
representatives of this class of potential Ku binding site failed to
distinguish themselves from DNA end binding in oligonucleotide competition experiments and were unable to be directly recognized by Ku
in direct binding experiments with oligonucleotide-containing covalently closed microcircles. In many of the previous studies, including the octamer motif study, DNA footprinting experiments have
demonstrated sequence-specific protection on linear DNA templates by Ku
(32-35, 67). However in these experiments, protection was either also
observed over the ends of the DNA fragments used in the footprinting
experiments (34), or the footprints shown did not present the ends of
the fragments employed in a manner in which DNA end binding could be
evaluated (32, 33, 35, 67). Together these results indicate that
accumulation of Ku over specific DNA sequences can occur in at least
two ways. First, for NRE1-like sequences, Ku can directly recognize a
DNA sequence element in B-form DNA. Second, Ku, which enters DNA at
ends, nicks or other structural features, can, as a result of
translocation, accumulate over "category two" DNA sequences.
This suggests the possibility that translocation of Ku from DNA ends is
somehow sensitive to the sequence being traversed. Thus, many of the
proposed sequence-specific binding sites that fail to bind Ku in the
absence of DNA ends, nicks, or other relevant structural features may
prove to be specific pause sites for translocating Ku that has
initiated its interaction with DNA through other determinants. Our
results also indicate that claims for sequence-specific Ku binding must
be carefully evaluated to distinguish between direct binding and
accumulation following entry onto DNA at a site remote from the
sequence occupied. Furthermore, while it is apparent that the sequences
unrelated to NRE1 over which Ku accumulates have the potential to
regulate transcription, the lack of direct binding by Ku places
additional mechanistic constraints on Ku access that must be carefully
evaluated in vivo. The diversity in the sequences shown to
accumulate Ku on linear DNA templates suggests that demonstrating, and
understanding, the requirements for the accumulation of Ku over these
sequences may require considerable additional investigation.
There are two alternative explanations for our DNA binding results that
we cannot completely exclude at this time. First, the incubation
conditions employed in this study may have precluded preferential
binding to sequences unrelated to NRE1. While buffering and ionic
strength in our binding assays is not discernibly different from that
employed in previous studies, our experiments differed from most others
in that Mg2+ was omitted from all binding reactions.
Previously, we have shown that Mg2+ facilitates the
translocation of Ku along DNA, which complicates the interpretation of
sequence-specific Ku binding to NRE1-containing microcircles (38).
Inclusion of Mg2+ in our binding assays however, failed to
promote Ku binding to octamer motif containing microcircles or increase
competition for direct binding to NRE1.4 Second, the
recombinant human Ku used in this study may lack some essential
property of endogenous Ku that restricts its sequence specificity.
However, in an extensive comparative analysis, we failed to determine
any difference in the NRE1 binding properties of recombinant Ku and Ku
purified from Jurkat T cells (38). Interestingly, Genersch et
al. (30) recently reported that the binding of Ku to linear DNA
fragments containing a transcriptional regulatory element from a
collagen gene promoter required association of a Ku dimer with the
TATA-binding protein (TBP). Thus, it is possible that the binding or
accumulation of Ku on many of the proposed sequences unrelated to NRE1
may require the interaction of Ku with additional proteins.
One additional interesting feature of NRE1 is that, in addition to Ku,
we have identified sequence specific single-stranded upper and
lower-stranded NRE1 binding activities (42). Furthermore, our previous
results with crude nuclear fractions and linear DNA templates suggest
that nuclear factor binding to double-stranded NRE1 induces structural
transitions in DNA flanking NRE1 in the presence of Mg2+
(69). As Ku has previously been reported to be the human DNA helicase
II (70), these results suggest that Ku binding to the MMTV LTR may act
to destabilize or unwind DNA around NRE1 in a manner that provides
access to the single-stranded NRE1-binding factors. Although repression
of MMTV transcription through NRE1 appears to require both Ku and
DNA-PKcs (38), the nature of these additional
single-stranded NRE1-binding factors and their contribution to
NRE1-mediated transcriptional regulation is currently under
investigation.5
Current models for DNA-PK-mediated phosphorylation propose that
association between Ku and DNA-PKcs is weak in the absence of DNA (1, 5). Therefore it has been suggested that catalytically active DNA-PK is formed through the recruitment of the
DNA-PKcs into a ternary complex in which both Ku and the
DNA-PKcs contact DNA (5). In other instances of ternary
complex formation by transcription factors on DNA, for example ternary
complex factor-serum response factor-DNA assembly, specific sequences
contribute to the binding of both factors to DNA (71). Thus, sequences
not required for serum response factor binding to DNA alone are
required for ternary complex assembly. This suggested the possibility
that the DNA sequence requirements for DNA-PK activity might differ from the requirements for sequence-specific Ku binding. However, in our
experiments the DNA preferences for Ku binding corresponded exactly
with the preferences for the phosphorylation of GR by DNA-PK. Thus,
either DNA-PKcs, unlike ternary complex factor, does not
have defined DNA sequence preferences or NRE1 contains all of the
sequence information required to accommodate the DNA sequence
preferences of Ku and DNA-PKcs.
The apparent requirement for colocalization of DNA-PK and GR substrate
on DNA in cis under our reaction conditions was striking. At
the substrate concentrations used in our assays, significant phosphorylation of GR was only detected when Ku binding sites and GREs
were present on the same DNA molecule. Furthermore, phosphorylation was
efficiently competed by an excess of either NRE1 or GREs sufficient to
titrate DNA-PK or GR onto different DNA molecules, but was refractory
to competition by covalently closed circular plasmids lacking both
motifs. While not an absolute requirement for substrate phosphorylation, preliminary experiments indicate that DNA
sequence-dependent colocalization of GR and DNA-PK on the
same DNA molecules increases the efficiency of phosphorylation of GR by
at least 2 orders of magnitude.6 These
results highlight the potential importance of direct, sequence-specific DNA targeting of DNA-PK for the modulation of nuclear processes through
DNA-PK-mediated Ser/Thr phosphorylation.
One of the striking features of the work on DNA-PK-mediated
transcription factor phosphorylation performed to date has been that,
while a large number of transcription factors are clearly DNA-PK
phosphorylation targets in vitro (1, 27), transcription factor phosphorylation by DNA-PK in the cell remains unproven. One
hypothesis suggested by our results is that DNA-PK-mediated phosphorylation of transcription factors is limited to transcriptional regulatory regions that contain binding sites for both the
transcription factor and DNA-PK. Thus, it is possible that only a small
proportion of a transcription factor population, those that bind to
regulatory regions to which DNA-PK is also recruited, become modified.
The corollary is that mutation of DNA-PK phosphorylation sites on transcription factors would be likely to result in gene specific regulatory effects.
Glucocorticoid receptor is a phosphoprotein, and the phosphorylation
state of GR changes in response to binding of agonists and antagonists
(72). While a number of Ser/Thr phosphorylation sites on GR have been
identified (72-75), none contain the sequence requirements for
modification by DNA-PK. Thus, while DNA-PK clearly has the potential to
phosphorylate GR, near-stoichiometric phosphorylation of GR by DNA-PK
does not appear to occur under the cell culture conditions examined to
date. However, the potential importance of DNA-PK-mediated GR
phosphorylation for the glucocorticoid responsiveness of genes
regulated through sequence-specific Ku binding sites is evidenced by
the dramatic inhibitory effect that Ku/DNA-PKcs have on the
ability of glucocorticoids to induce MMTV transcription (38).
Our mapping of the phosphorylation of a GST-GR fusion protein by DNA-PK
on the MMTV LTR in vitro identified Ser-527 of rat GR as a
potential DNA-PK phosphorylation site. Similar consensus DNA-PK
recognition motifs exist in mouse and human
GRs.7 Interestingly, Ser-527 is in the
exposed and apparently flexible hinge region of GR that links the DNA
binding domain to the ligand binding domain (76). Thus, this serine may
be accessible in the full-length GR. While not in a region of GR
containing a transcriptional activation function, there is reason to
suspect that phosphorylation in the hinge region of the receptor might
affect transcriptional regulation. There is recent evidence that the
ligand binding and DNA binding domains maintain important interactions
that could be potentially modified by phosphorylation in the receptor
hinge region (77). Phosphorylation in the hinge region of GR could also
potentially affect receptor dimerization (78). It is also possible that
phosphorylation of Ser-527 somehow modifies the potential of the
immediately adjacent nuclear localization sequence of GR (79).
While this is the first report indicating the potential for GR
phosphorylation in the receptor hinge region, modification of serines
in the hinge region of other steroid hormone receptors has been
proposed to influence the ability of these receptors to activate
transcription. Substitutions of alanine for Ser-650 and Ser-530 in the
hinge regions of human androgen receptor and chicken progesterone
receptor, respectively, reduced the ability of these receptors to
activate transcription by up to 30% (80-82).
In order to clearly resolve the potential of sequence-directed DNA-PK
modification of transcription factors to influence their ability to
regulate transcription, it will be necessary to first identify all of
the DNA-PK phosphorylation sites on the surface of potential DNA-PK
targets. Preliminary experiments with GR indicate that liganded
full-length receptor can be phosphorylated at two places by DNA-PK when
both are bound to the MMTV LTR.7 Following confirmation of
the identity of these two phosphorylation sites, we will be able to
directly evaluate the role of modification of these residues on the
ability of GR to regulate transcription.
FOOTNOTES
*
This work was supported by an operating grant from the
Medical Research Council of Canada (to R. J. G. H.). The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Recipient of a studentship from the National Sciences and
Engineering Research Council of Canada.
**
Scholar of the Medical Research Council of Canada and Cancer
Research Society Inc. To whom correspondence should be addressed: Loeb
Medical Research Institute, Ottawa Civic Hospital, 1053 Carling Ave.,
Ottawa, Ontario, Canada K1Y 4E9. Tel.: 613-798-5555 (ext. 6283); Fax:
613-761-5365; E-mail: hache{at}civich.ottawa.on.ca.
1
The abbreviations used are: DNA-PK,
DNA-dependent protein kinase; DNA-PKcs,
DNA-dependent protein kinase catalytic subunit; NRE1,
negative regulatory element 1; MMTV, mouse mammary tumor virus; LTR,
long terminal repeat; GR, glucocorticoid receptor; Oct-1, octamer
transcription factor 1; GST, glutathione S-transferase; EMSA, electrophoretic mobility shift assay; PAGE, polyacrylamide gel
electrophoresis; HTLV, human T cell leukemia virus; IAP, intracisternal A particle; PRE, plasmacytoma repressor factor binding site; DBD, DNA
binding domain; GRE, glucocorticoid-responsive element; PSE, proximal
U1 promoter sequence element; HSE, heat shock response element; bp,
base pair(s); HPLC, high pressure liquid chromatography; Ab,
antibody.
2
W. Giffin and R. J. G. Haché, data not
shown.
3
J. Kwast-Welfeld, Y. Zhang, N. Weigel, and R. J. G. Haché, unpublished observation.
5
H. Torrance, W. Giffin, and R. J. G. Haché, manuscript in preparation.
6
H. Torrance, W. Giffin, and R. J. G. Haché, unpublished observation.
7
D. J. Rodda, W. Giffin, and R. J. G. Haché, unpublished observation.
4
W. Griffin and R. J. G. Haché, unpublished
observation.
Acknowledgments
We thank our colleagues Dr. Caroline
Schild-Poulter and Heather Torrance for their careful reading of this
manuscript.
REFERENCES
-
Anderson, C. W., and Lees-Miller, S. P.
(1992)
Crit. Rev. Eukaryot. Gene Exp.
2,
283-314
[Medline]
[Order article via Infotrieve]
-
Anderson, C. W., Connelly, M. A., Zhang, H., Sipley, J. D., Leesmiller, S. P., Sakaguchi, K., Ullrich, S. J., Jackson, S. P., and Appella, E.
(1994)
J. Protein Chem.
13,
500-501
-
Morozov, V. E., Falzon, M., Anderson, C. W., and Kuff, E. L.
(1994)
J. Biol. Chem.
269,
16684-16688
[Abstract/Free Full Text]
-
Suwa, A., Hirakata, M., Takeda, Y., Jesch, S. A., Mimori, T., and Hardin, J. A.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
6904-6908
[Abstract/Free Full Text]
-
Gottlieb, T. M., and Jackson, S. P.
(1993)
Cell
72,
131-142
[CrossRef][Medline]
[Order article via Infotrieve]
-
Mimori, T., Akizuki, M., Yamagata, H., Inada, S., Yoshida, L., and Homma, H.
(1981)
J. Clin. Invest.
68,
611-620
-
Mimori, T., Hardin, J. A., and Steitz, J. A.
(1986)
J. Biol. Chem.
261,
2274-2278
[Abstract/Free Full Text]
-
de Vries, E., van Driel, W., Bergsma, W. G., Arnberg, A. C., and van der Vliet, P. C.
(1989)
J. Mol. Biol.
208,
65-78
[CrossRef][Medline]
[Order article via Infotrieve]
-
Falzon, M., Fewell, J. W., and Kuff, E. L.
(1993)
J. Biol. Chem.
268,
10546-10552
[Abstract/Free Full Text]
-
Paillard, S., and Strauss, F.
(1991)
Nucleic Acids Res.
19,
5619-5624
[Abstract/Free Full Text]
-
Hartley, K. O., Gell, D., Smith, G. C. M., Zhang, H., Divecha, N., Connelly, M. A., Admon, A., Lees-Miller, S. P., Anderson, C. W., and Jackson, S. P.
(1995)
Cell
82,
849-856
[CrossRef][Medline]
[Order article via Infotrieve]
-
Jackson, S. P.
(1995)
Curr. Biol.
5,
1210-1212
[CrossRef][Medline]
[Order article via Infotrieve]
-
Zakian, V. A.
(1995)
Cell
82,
685-687
[CrossRef][Medline]
[Order article via Infotrieve]
-
Roth, D. B., Lindahl, T., and Gellert, M.
(1995)
Curr. Biol.
5,
496-499
[CrossRef][Medline]
[Order article via Infotrieve]
-
Taccioli, G. E., Gottlieb, T. M., Blunt, T., Priestley, A., Demengeot, J., Mizuta, R., Lehmann, A. R., Alt, F. W., Jackson, S. P., and Jeggo, P. A.
(1994)
Science
265,
1442-1445
[Abstract/Free Full Text]
-
Smider, V., Rathmell, W. K., Lieber, M. R., and Chu, G.
(1994)
Science
266,
288-292
[Abstract/Free Full Text]
-
Blunt, T., Finnie, N. J., Taccioli, G. E., Smith, G. C. M., Demengeot, J., Gottlieb, T. M., Mizuta, R., Varghese, A. J., Alt, F. W., Jeggo, P. A., and Jackson, S. P.
(1995)
Cell
80,
813-823
[CrossRef][Medline]
[Order article via Infotrieve]
-
Boubnov, N. V., Hall, K. T., Wills, Z., Lee, S. E., He, D. M., Benjamin, D. M., Pulaski, C. R., Band, H., Reeves, W., Hendrickson, E. A., and Weaver, D. T.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
890-894
[Abstract/Free Full Text]
-
Getts, R. C., and Stamato, T. D.
(1994)
J. Biol. Chem.
269,
15981-15984
[Abstract/Free Full Text]
-
Kirchgessner, C. U., Patil, C. K., Evans, J. W., Cuomo, C. A., Fried, L. M., Carter, T., Oettinger, M. A., and Brown, J. M.
(1995)
Science
267,
1178-1183
[Abstract/Free Full Text]
-
Lees-Miller, S. P., Godbout, R., Chan, D. W., Weinfeld, M., Day, R. S., Barron, G. M., and Allalunis-Turner, J.
(1995)
Science
267,
1183-1185
[Abstract/Free Full Text]
-
Peterson, S. R., Jesch, S. A., Chamberlin, T. N., Dvir, A., Rabindran, S. K., Wu, C., and Dynan, W. S.
(1995)
J. Biol. Chem.
270,
1449-1454
[Abstract/Free Full Text]
-
Rathmell, W. K., and Chu, G.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
7623-7627
[Abstract/Free Full Text]
-
Kuhn, A., Stefanovsky, V., and Grummt, I.
(1993)
Nucleic Acids Res.
21,
2057-2063
[Abstract/Free Full Text]
-
Kuhn, A., Gottlieb, T. M., Jackson, S. P., and Grummt, I.
(1995)
Genes Dev.
9,
193-203
[Abstract/Free Full Text]
-
Labhart, P.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
2934-2938
[Abstract/Free Full Text]
-
Finnie, N., Gottlieb, T., Hartley, K., and Jackson, S. P.
(1993)
Biochem. Soc. Trans.
21,
930-935
[Medline]
[Order article via Infotrieve]
-
Weigel, N. L., Carter, T. H., Schrader, W. T., and O'Malley, B. W.
(1992)
Mol. Endocrinol.
6,
8-14
[Abstract/Free Full Text]
-
Maldonado, E., Shiekhattar, R., Sheldon, M., Cho, H., Drapkin, R., Rickert, P., Lees, E., Anderson, C. W., Linn, S., and Reinberg, D.
(1996)
Nature
381,
86-89
[CrossRef][Medline]
[Order article via Infotrieve]
-
Genersch, E., Eckerskorn, C., Lottspeich, F., Herzog, C., Kuhn, K., and Poschl, E.
(1995)
EMBO J.
14,
791-800
[Medline]
[Order article via Infotrieve]
-
Kim, D., Ouyang, H., Yang, S.-H., Nussenzweig, A., Burgman, P., and Li, G. C.
(1995)
J. Biol. Chem.
270,
15277-15284
[Abstract/Free Full Text]
-
Knuth, M. W., Gunderson, S. I., Thompson, N. E., Strasheim, L. A., and Burgess, R. R.
(1990)
J. Biol. Chem.
265,
17911-17920
[Abstract/Free Full Text]
-
Liu, E. S., and Lee, A. S.
(1991)
Nucleic Acids Res.
19,
5425-5431
[Abstract/Free Full Text]
-
May, G., Sutton, C., and Gould, H.
(1991)
J. Biol. Chem.
266,
3052-3059
[Abstract/Free Full Text]
-
Messier, H., Fuller, T., Mangal, S., Brickner, H., Igarashi, S., Gaikwad, J., Fotedar, R., and Fotedar, A.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
2685-2689
[Abstract/Free Full Text]
-
Okumura, K., Takagi, S., Sakaguchi, G., Naito, K., Minoura-Tada, N., Kobayashi, H., Mimori, T., Hinuma, Y., and Igarashi, H.
(1994)
FEBS Lett.
356,
94-100
[CrossRef][Medline]
[Order article via Infotrieve]
-
DiCroce, P. A., and Krontiris, T. G.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10137-10141
[Abstract/Free Full Text]
-
Giffin, W., Torrance, H., Rodda, D. J., Prefontaine, G. G., Pope, L., and Hache, R. G. J.
(1996)
Nature
380,
265-268
[CrossRef][Medline]
[Order article via Infotrieve]
-
Bruggemeier, U., Kalff, M., Franke, S., Scheidereit, C., and Beato, M.
(1991)
Cell
64,
565-572
[CrossRef][Medline]
[Order article via Infotrieve]
-
Archer, T. K., Lefebvre, P., Wolford, R. G., and Hager, G. L.
(1992)
Science
255,
1573-1576
[Abstract/Free Full Text]
-
Truss, M., Bartsch, J., Schelbert, A., Hache, R. J. G., and Beato, M.
(1995)
EMBO J
14,
1737-1751
[Medline]
[Order article via Infotrieve]
-
Giffin, W., Torrance, H., Saffran, H., MacLeod, H. L., and Hache, R. J. G.
(1994)
J. Biol. Chem.
269,
1449-1459
[Abstract/Free Full Text]
-
Ono, M., Tucker, P. W., and Capra, J. D.
(1994)
Nucleic Acids Res.
22,
3918-3924
[Abstract/Free Full Text]
-
Rusconi, S., and Yamamoto, K. R.
(1987)
EMBO J.
6,
1309-1315
[Medline]
[Order article via Infotrieve]
-
Schena, M., Freedman, L. P., and Yamamoto, K. R.
(1989)
Genes Dev.
3,
1590-1601
[Abstract/Free Full Text]
-
Mink, S., Ponta, H., and Cato, A. C.
(1990)
Nucleic Acids Res.
18,
2017-2024
[Abstract/Free Full Text]
-
Reeves, W. H.
(1985)
J. Exp. Med.
161,
18-39
[Abstract/Free Full Text]
-
Lai, J. S., and Herr, W.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
6958-6962
[Abstract/Free Full Text]
-
Gametchu, B., and Harrison, R.
(1984)
Endocrinology
114,
274-279
[Abstract/Free Full Text]
-
Fujita, T., Nolan, G. P., Ghosh, S., and Baltimore, D.
(1992)
Genes Dev.
6,
775-787
[Abstract/Free Full Text]
-
Fuernkranz, H. A., Wang, Y., Karathanasis, S. K., and Mak, P.
(1994)
Nucleic Acids Res.
22,
5665-5671
[Abstract/Free Full Text]
-
Gualberto, A., Patrick, R. M., and Walsh, K.
(1992)
Genes Dev.
6,
815-824
[Abstract/Free Full Text]
-
Zhang, Y., Beck, C. A., Poletti, A., Edwards, D. P., and Weigel, N. L.
(1994)
J. Biol. Chem.
269,
31034-31040
[Abstract/Free Full Text]
-
Drapeau, G. R.
(1980)
J. Biol. Chem.
255,
839-840
[Abstract/Free Full Text]
-
West, M. H. P., Wu, S., and Bonner, W. M.
(1984)
Electrophoresis
5,
133-138
-
Sullivan, S., and Wong, C. W.
(1991)
Anal. Biochem.
197,
65-68
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kakkis, E., and Calame, K.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
7031-7035
[Abstract/Free Full Text]
-
Kakkis, E., Riggs, K. J., Gillespie, W., and Calame, K.
(1989)
Nature
339,
718-722
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lee, J. W., Moffitt, P. G., Morley, K. L., and Peterson, D. O.
(1991)
J. Biol. Chem.
266,
24101-24108
[Abstract/Free Full Text]
-
Morley, K. L., Toohey, M. G., and Peterson, D. O.
(1987)
Nucleic Acids Res.
15,
6973-6989
[Abstract/Free Full Text]
-
Lefebvre, P., Berard, D. S., Cordingley, M. G., and Hager, G. L.
(1991)
Mol. Cell. Biol.
11,
2529-2537
[Abstract/Free Full Text]
-
Falzon, M., and Kuff, E. L.
(1989)
J. Biol. Chem.
264,
21915-21922
[Abstract/Free Full Text]
-
Falzon, M., and Kuff, E. L.
(1990)
J. Biol. Chem.
265,
13084-13090
[Abstract/Free Full Text]
-
Bhargava, A. K., Li, Z., and Weissman, S. M.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
10260-10264
[Abstract/Free Full Text]
-
Carter, T., Vancurova, I., Sun, I., Lou, W., and DeLeon, S.
(1990)
Mol. Cell. Biol.
10,
6460-6471
[Abstract/Free Full Text]
-
Picard, D., and Yamamoto, K. R.
(1987)
EMBO J.
6,
3333-3340
[Medline]
[Order article via Infotrieve]
-
Falzon, M., and Kuff, E. L.
(1991)
Mol. Cell. Biol.
11,
117-125
[Abstract/Free Full Text]
-
Blier, P. R., Griffith, A. J., Craft, J., and Hardin, J. A.
(1993)
J. Biol. Chem.
268,
7594-7601
[Abstract/Free Full Text]
-
Giffin, W., and Haché, R. J. G.
(1995)
DNA Cell Biol.
14,
1025-1035
[Medline]
[Order article via Infotrieve]
-
Tuteja, N., Tuteja, R., Ochem, A., Taneja, P., Huang, N. W., Simoncsits, A., Susic, S., Rahman, K., Marusic, L., Chen, J. Q., Zhang, J. W., Wang, S. G., Pongor, S., and Falaschi, A.
(1994)
EMBO J.
13,
4991-5001
[Medline]
[Order article via Infotrieve]
-
Shaw, P. E., Schroter, H., and Nordheim, A.
(1989)
Cell
56,
563-572
[CrossRef][Medline]
[Order article via Infotrieve]
-
Bodwell, J. E., Hu, J. M., Orti, E., and Munck, A.
(1995)
J. Steroid Biochem. Mol. Biol.
52,
135-140
[CrossRef][Medline]
[Order article via Infotrieve]
-
Bodwell, J. E., Orti, E., Coull, J. M., Pappin, D. J. C., Smith, L. I., and Swift, F.
(1991)
J. Biol. Chem.
266,
7549-7555
[Abstract/Free Full Text]
-
Borror, K. C., Garabedian, M. J., and DeFranco, D. B.
(1995)
Steroids
60,
375-382
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hsu, S., and DeFranco, D. B.
(1995)
J. Biol. Chem.
270,
3359-3364
[Abstract/Free Full Text]
-
Giguere, V., Hollenberg, S. M., Rosenfeld, M. G., and Evans, R. E.
(1986)
Cell
46,
645-652
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lefstin, J. A., Thomas, J. R., and Yamamoto, K. R.
(1994)
Genes Dev.
8,
2842-2856
[Abstract/Free Full Text]
-
Cairns, W., Cairns, C., Pongratz, I., Poellinger, L., and Okret, S.
(1991)
J. Biol. Chem.
266,
11221-11226
[Abstract/Free Full Text]
-
Madan, A. P., and Defranco, D. B.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
3588-3592
[Abstract/Free Full Text]
-
Poletti, A., Connelly, O. M., Mcdonnell, D. P., Schrader, W. T., O'Malley, B. W., and Weigel, N. L.
(1993)
Biochemistry
32,
9563-9569
[CrossRef][Medline]
[Order article via Infotrieve]
-
Weigel, N. L., Bai, W., Zhang, Y., Beck, C. A., Edwards, D. P., and Poletti, A.
(1995)
J. Steroid Biochem. Mol. Biol.
53,
509-514
[CrossRef][Medline]
[Order article via Infotrieve]
-
Zhou, Z. X., Kemppainen, J. A., and Wilson, E. M.
(1995)
Mol. Endocrinol.
9,
605-615
[Abstract/Free Full Text]
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. A. Ponguta, C. W. Gregory, F. S. French, and E. M. Wilson
Site-specific Androgen Receptor Serine Phosphorylation Linked to Epidermal Growth Factor-dependent Growth of Castration-recurrent Prostate Cancer
J. Biol. Chem.,
July 25, 2008;
283(30):
20989 - 21001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Shank, J. B. Kelley, D. Gioeli, C.-S. Yang, A. Spencer, L. A. Allison, and B. M. Paschal
Activation of the DNA-dependent Protein Kinase Stimulates Nuclear Export of the Androgen Receptor in Vitro
J. Biol. Chem.,
April 18, 2008;
283(16):
10568 - 10580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Masson, S. Bury-Mone, E. Guiot, A. Saez-Cirion, D. Schoevaert-Brossault, C. Brachet-Ducos, O. Delelis, F. Subra, L. Jeanson-Leh, and J.-F. Mouscadet
Ku80 Participates in the Targeting of Retroviral Transgenes to the Chromatin of CHO Cells
J. Virol.,
August 1, 2007;
81(15):
7924 - 7932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jeyakumar, X.-f. Liu, H. Erdjument-Bromage, P. Tempst, and M. K. Bagchi
Phosphorylation of Thyroid Hormone Receptor-associated Nuclear Receptor Corepressor Holocomplex by the DNA-dependent Protein Kinase Enhances Its Histone Deacetylase Activity
J. Biol. Chem.,
March 30, 2007;
282(13):
9312 - 9322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Q. Dong and F. Liu
PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle
Am J Physiol Endocrinol Metab,
August 1, 2005;
289(2):
E187 - E196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Katz, M. A. Beer, J. M. Levorse, and S. M. Tilghman
Functional Characterization of a Novel Ku70/80 Pause Site at the H19/Igf2 Imprinting Control Region
Mol. Cell. Biol.,
May 15, 2005;
25(10):
3855 - 3863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Mayeur, W.-J. Kung, A. Martinez, C. Izumiya, D. J. Chen, and H.-J. Kung
Ku Is a Novel Transcriptional Recycling Coactivator of the Androgen Receptor in Prostate Cancer Cells
J. Biol. Chem.,
March 18, 2005;
280(11):
10827 - 10833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang, R. Fang, J.-Y. Cho, T. A. Libermann, and P. Oettgen
Positive and Negative Modulation of the Transcriptional Activity of the ETS Factor ESE-1 through Interaction with p300, CREB-binding Protein, and Ku 70/86
J. Biol. Chem.,
June 11, 2004;
279(24):
25241 - 25250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Hammer, N. A. Compagnone, J.-L. Vigne, S. R. Bair, and S. H. Mellon
Transcriptional Regulation of P450scc Gene Expression in the Embryonic Rodent Nervous System
Endocrinology,
February 1, 2004;
145(2):
901 - 912.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schild-Poulter, A. Shih, N. C. Yarymowich, and R. J. G. Hache
Down-Regulation of Histone H2B by DNA-Dependent Protein Kinase in Response to DNA Damage through Modulation of Octamer Transcription Factor 1
Cancer Res.,
November 1, 2003;
63(21):
7197 - 7205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Soubeyrand, L. Pope, B. Pakuts, and R. J. G. Hache
Threonines 2638/2647 in DNA-PK Are Essential for Cellular Resistance to Ionizing Radiation
Cancer Res.,
March 15, 2003;
63(6):
1198 - 1201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Jeanson and J.-F. Mouscadet
Ku Represses the HIV-1 Transcription. IDENTIFICATION OF A PUTATIVE Ku BINDING SITE HOMOLOGOUS TO THE MOUSE MAMMARY TUMOR VIRUS NRE1 SEQUENCE IN THE HIV-1 LONG TERMINAL REPEAT
J. Biol. Chem.,
February 8, 2002;
277(7):
4918 - 4924.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Soubeyrand, H. Torrance, W. Giffin, W. Gong, C. Schild-Poulter, and R. J. G. Hache
Activation and autoregulation of DNA-PK from structured single-stranded DNA and coding end hairpins
PNAS,
July 24, 2001;
(2001)
171211398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Bertinato, C Schild-Poulter, and R. Hache
Nuclear localization of Ku antigen is promoted independently by basic motifs in the Ku70 and Ku80 subunits
J. Cell Sci.,
January 1, 2001;
114(1):
89 - 99.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Hammarsten, L. G. DeFazio, and G. Chu
Activation of DNA-dependent Protein Kinase by Single-stranded DNA Ends
J. Biol. Chem.,
January 21, 2000;
275(3):
1541 - 1550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-L. Hsu, D. Gilley, E. H. Blackburn, and D. J. Chen
Ku is associated with the telomere in mammals
PNAS,
October 26, 1999;
96(22):
12454 - 12458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Page, B. Carr, K. R. Anders, A. Grimson, and P. Anderson
SMG-2 Is a Phosphorylated Protein Required for mRNA Surveillance in Caenorhabditis elegans and Related to Upf1p of Yeast
Mol. Cell. Biol.,
September 1, 1999;
19(9):
5943 - 5951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Giffin, W. Gong, C. Schild-Poulter, and R. J. G. Hache
Ku Antigen-DNA Conformation Determines the Activation of DNA-Dependent Protein Kinase and DNA Sequence-Directed Repression of Mouse Mammary Tumor Virus Transcription
Mol. Cell. Biol.,
June 1, 1999;
19(6):
4065 - 4078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nueda, F. Hudson, N. F. Mivechi, and W. S. Dynan
DNA-dependent Protein Kinase Protects against Heat-induced Apoptosis
J. Biol. Chem.,
May 21, 1999;
274(21):
14988 - 14996.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Ruiz, D. Matheos, G. B. Price, and M. Zannis-Hadjopoulos
OBA/Ku86: DNA Binding Specificity and Involvement in Mammalian DNA Replication
Mol. Biol. Cell,
March 1, 1999;
10(3):
567 - 580.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. G. A. Savory, B. Hsu, I. R. Laquian, W. Giffin, T. Reich, R. J. G. Hache, and Y. A. Lefebvre
Discrimination between NL1- and NL2-Mediated Nuclear Localization of the Glucocorticoid Receptor
Mol. Cell. Biol.,
February 1, 1999;
19(2):
1025 - 1037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N Grandvaux, S Grizot, P. Vignais, and M. Dagher
The Ku70 autoantigen interacts with p40phox in B lymphocytes
J. Cell Sci.,
January 2, 1999;
112(4):
503 - 513.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Boruk, J. G. A. Savory, and R. J. G. Haché
AF-2-Dependent Potentiation of CCAAT Enhancer Binding Protein {beta}-Mediated Transcriptional Activation by Glucocorticoid Receptor
Mol. Endocrinol.,
November 1, 1998;
12(11):
1749 - 1763.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Muñoz, M. Z. Zdzienicka, J.-M. Blanchard, and J. Piette
Hypersensitivity of Ku-Deficient Cells toward the DNA Topoisomerase II Inhibitor ICRF-193 Suggests a Novel Role for Ku Antigen during the G2 and M Phases of the Cell Cycle
Mol. Cell. Biol.,
October 1, 1998;
18(10):
5797 - 5808.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Torrance, W. Giffin, D. J. Rodda, L. Pope, and R. J. G. Hache
Sequence-specific Binding of Ku Autoantigen to Single-stranded DNA
J. Biol. Chem.,
August 14, 1998;
273(33):
20810 - 20819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nishishita, T. Okazaki, T. Ishikawa, T. Igarashi, K. Hata, E. Ogata, and T. Fujita
A Negative Vitamin D Response DNA Element in the Human Parathyroid Hormone-related Peptide Gene Binds to Vitamin D Receptor Along with Ku Antigen to Mediate Negative Gene Regulation by Vitamin D
J. Biol. Chem.,
May 1, 1998;
273(18):
10901 - 10907.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.V. Reddy, O. Alcantara, and D.H. Boldt
Analysis of DNA Binding Proteins Associated With Hemin-Induced Transcriptional Inhibition. The Hemin Response Element Binding Protein Is a Heterogeneous Complex That Includes the Ku Protein
Blood,
March 1, 1998;
91(5):
1793 - 1801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Ochem, D. Skopac, M. Costa, T. Rabilloud, L. Vuillard, A. Simoncsits, M. Giacca, and A. Falaschi
Functional Properties of the Separate Subunits of Human DNA Helicase II/Ku Autoantigen
J. Biol. Chem.,
November 21, 1997;
272(47):
29919 - 29926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Huang, A. Nueda, S. Yoo, and W. S. Dynan
Heat Shock Transcription Factor 1 Binds Selectively in Vitro to Ku Protein and the Catalytic Subunit of the DNA-dependent Protein Kinase
J. Biol. Chem.,
October 10, 1997;
272(41):
26009 - 26016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Giampuzzi, G. Botti, M. Di Duca, L. Arata, G. Ghiggeri, R. Gusmano, R. Ravazzolo, and A. Di Donato
Lysyl Oxidase Activates the Transcription Activity of Human Collagene III Promoter. POSSIBLE INVOLVEMENT OF Ku ANTIGEN
J. Biol. Chem.,
November 10, 2000;
275(46):
36341 - 36349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-P. Li, S. Periyasamy, T. J. Jones, and E. R. Sanchez
Heat and Chemical Shock Potentiation of Glucocorticoid Receptor Transactivation Requires Heat Shock Factor (HSF) Activity. MODULATION OF HSF BY VANADATE AND WORTMANNIN
J. Biol. Chem.,
August 18, 2000;
275(34):
26058 - 26065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-M. Ou, J. M. Storring, N. Kushwaha, and P. R. Albert
Heterodimerization of Mineralocorticoid and Glucocorticoid Receptors at a Novel Negative Response Element of the 5-HT1A Receptor Gene
J. Biol. Chem.,
April 20, 2001;
276(17):
14299 - 14307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schild-Poulter, L. Pope, W. Giffin, J. C. Kochan, J. K. Ngsee, M. Traykova-Andonova, and R. J. G. Hache
The Binding of Ku Antigen to Homeodomain Proteins Promotes Their Phosphorylation by DNA-dependent Protein Kinase
J. Biol. Chem.,
May 11, 2001;
276(20):
16848 - 16856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Soubeyrand, H. Torrance, W. Giffin, W. Gong, C. Schild-Poulter, and R. J. G. Hache
Activation and autoregulation of DNA-PK from structured single-stranded DNA and coding end hairpins
PNAS,
August 14, 2001;
98(17):
9605 - 9610.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|